The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis-ultrastructural findings. the first report in pediatric patients

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 3, 2013, Pages 352-357

  Lotowska, Joanna Maria ^a   Sobaniec Lotowska, Maria Elzbieta ^a   Lebensztejn, Dariusz Marek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Activated Kupffer cells macrophages; Erythrophagocytosis; Fibrosis; Hepatic nonparenchymal cells; Morphogenesis of pediatric nonalcoholic steatohepatitis; Ultrastructure

Indexed keywords

GLUTARALDEHYDE; PARAFORMALDEHYDE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; FIBROSIS; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; KUPFFER CELL; LIVER BIOPSY; LIVER CELL; LYSOSOME; MACROPHAGE; MALE; MITOCHONDRION; MORPHOGENESIS; NONALCOHOLIC FATTY LIVER; PHAGOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STELLATE CELL; STEM CELL; TRANSMISSION ELECTRON MICROSCOPY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLLAGEN; FATTY LIVER; FEMALE; GOLGI APPARATUS; HUMANS; KUPFFER CELLS; LIVER CIRRHOSIS; LYSOSOMES; MALE; MITOCHONDRIA;

EID: 84875530122     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.746390     Document Type: Article

References (35)

1. Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, et al. Portal chronic inflammation in nonalcoholic liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009;49:809-20.
2. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepato-cellular carcinoma. Gastroentetrology 2002;123:134-40.
3. Byrne CD. Hypoxia and non alcoholic fatty liver disease. Clin Sci (Lond) 2009;118:397-400.
4. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28:370-9.
5. Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB, et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011;106:460-8.
6. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and ductular reaction. Gastroenterology 2007;133:80-90.
7. Sobaniec-Lotowska ME, Lebensztejn DM, Lotowska JM, Kanczuga-Koda L, Sulkowski S. Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohe-patitis. Adv Med Sci 2011;56:172-9.
8. Brunt EM. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis 2009;13:533-44.
9. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
10. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59:1265-9.
11. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic liver disease. Hepatology 2005;42:641-9.
12. Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease. Am J Gastroenterol 2003;98: 1664-5.
13. Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. J Gastro-enterol 2004;39:1215-18.
14. Washington K, Wright K, Shyr Y, Hunter EB, Olson S, Raiford DS. Hepatic stellate cell activation in nonalcoholic staetohepatitis and fatty liver. Hum Pathol 2000;31:822-8.
15. Zhao J, Zhou G, Li M, Li W, Lü J, Xiong L, et al. A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. Scand J Gastroenterol 2010;45:1360-71.
16. Fan J, Zhong L, Wang G, Wu X, Jing D, Zhang P. The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet. Zhonghua Gan Zang Bing Za Zhi 2001;9:16-18.
17. Kawada N, Otogawa K. Role of oxidative stress and Kupffer cells in hepatic fibrosis. J Gastroenterol Hepatol 2007;22: S85-6.
18. Kiki I, Altunkaynak BZ, Altunkaynak ME, Vuraler O, Unal D, Kaplan S. Effect of high fat diet on the volume of liver and quantitative feature of Kupffer cells in the female rat: a stereological and ultrastructural study. Obes Surg 2007; 17:1381-8.
19. Otogawa K, Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, et al. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am J Pathol 2007;170:967-80.
20. Sato N. Central role of mitochondria in metabolic regulation of liver pathophysiology. J Gastroenterol Hepatol 2007;22: S1-6.
21. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, et al. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 2006;55:415-24.
22. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008;48:474-86.
23. Farrel GC, Teoh NC, McCuskey RS. Hepatic microcircu-lation in fatty liver disease. Anat Res (Hoboken) 2008;291: 684-92.
24. Malaguarnera L, Rosa MD, Zambito AM, dell'Ombra N, Marco RD, Malaguarnera M. Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. Am J Gastroenterol 2006;101:2060-9.
25. Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Nicoletti F, Malaguarnera M. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 2006;55:1313-20.
26. Park JW, Jeong G, Kim SJ, Kim MK, Park SM. Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohisto-chemical findings in younger Asian patients. J Gastroenterol Hepatol 2007;22:461-3.
27. Sumida Y, Yoshikawa T, Okanoue T. Role of hepatic iron in non-alcoholic steatohepatitis. Hepatol Res 2009;39:213-22.
28. Fujita N, Takei Y. Iron overload in nonalcoholic steatohe-patitis. Adv Clin Chem 2011;55:105-32.
29. Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008;10:67-72.
30. Hesham A-Kader H. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr 2009;5:245-54.
31. Patton HM, Lavine JE, Van Natta ML, Schwinmmer JB, Kleiner D, Molleston J. Nonalcoholic Steatohepatitis Clinical Research Network. Clinical correlations of histopa-thology in pediatric nonalcoholic steatohepatitis. Gastroen-terology 2008;135:1961-71.
32. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010; 105:2093-102.
33. Roberts EA. Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci 2005;10:2306-18.
34. Lebensztejn DM, Kowalczuk D, Tarasów E, Skiba E, Kaczmarski M. Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD. Adv Med Sci 2010;55:74-9.
35. Sobaniec-Lotowska ME, Lotowska JM. The role of Kupffer cells in the pathogenesis of non-alcoholic steatohepatitis: immunohistochemical and ultrastructural findings in pediatric patients. Falk Symposium 181, Munich/Germany, February 8-9, 2012;28.